Pressure Biosciences INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Pressure BioSciences, Inc. reports a net loss of $35.2 million for 2023, while strategically shifting its focus to its Ultra Shear Technology platform.